SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-019345
Filing Date
2018-03-21
Accepted
2018-03-21 16:45:48
Documents
4
Period of Report
2018-03-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-8805_18k.htm 8-K 27796
2 EX-1.1 a18-8805_1ex1d1.htm EX-1.1 198750
3 EX-5.1 a18-8805_1ex5d1.htm EX-5.1 21294
4 GRAPHIC g88051kii001.jpg GRAPHIC 2432
  Complete submission text file 0001104659-18-019345.txt   252440
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 18704894
SIC: 2834 Pharmaceutical Preparations